As HER2-low and ultralow classifications reshape metastatic breast cancer (mBC) treatment pathways, many practices still face real-world barriers to accurate testing and timely reporting. Intra-laboratory variability, limited uptake of emerging assays, and fragmented communication across care teams can all lead …
Alzheimer’s disease (AD) affects more than 55 million individuals worldwide, leading to progressive decline in memory, cognition, and ability to perform activities of daily living (ADLs). Recent advancements in amyloid-targeting therapies (ATTs) have created new opportunities to alter disease progression …
Idiopathic hypersomnia (IH) is a life-disrupting condition characterized by excessive daytime sleepiness (EDS) that makes waking up a daily struggle, limits productivity, and erodes overall quality of life. For many patients with IH, the journey to diagnosis is long and …
Health care professionals involved in lupus nephritis (LN) care face challenges in recognizing early signs of renal involvement in systemic lupus erythematosus, navigating an increasingly expanding treatment landscape, and addressing persistent disparities affecting Black and Latine patients. Missed or delayed …
Health care professionals (HCPs) managing lupus nephritis (LN) face persistent gaps in equitable care, with disproportionate burden and worse outcomes among Black and Latine patients driven by structural barriers, delayed recognition, and inconsistent access to specialty services. Despite updated guidelines …
Across diverse global settings, patient engagement and sustained adherence remain major challenges in HIV prevention, particularly with pre-exposure prophylaxis (PrEP). Barriers such as insufficient provider training in communication strategies, in addition to broader issues such as stigma, limited health literacy, …
As HIV prevention strategies continue to evolve, healthcare professionals across the globe face persistent knowledge gaps in evaluating and integrating the latest pre-exposure prophylaxis (PrEP) options, including long-acting injectable (LAI) agents. Many clinicians worldwide remain unfamiliar with the mechanisms of …
Men face unique behavioral health challenges that often go unrecognized due to stigma, cultural norms, and underreporting, leading to disparities in diagnosis and care. Across their lifespan, men’s mental health concerns frequently appear through externalizing behaviors, physical symptoms, or social …
Women experience a disproportionate burden of behavioral health conditions across their lifespan, yet unique clinical presentations often go underrecognized due to persistent stigma, gender disparities, and limited integration of mental health within women’s health care. From adolescence—when depression, anxiety, and …